Mark Lansdown
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Nephrology top 5%
- Parathyroid Disorders and Treatments
Papers in
- Co-authors
- Valerie Speirs (5 shared papers)Andrew M. Hanby (3 shared papers)P J Carder (5 shared papers)Andrew Scarsbrook (2 shared papers)Chirag N. Patel (1 shared paper)G. Skliris (2 shared papers)Sally Lane (3 shared papers)Kieran Horgan (5 shared papers)
- Journals
- British journal of surgery (5 papers)European Journal of Surgical Oncology (4 papers)Human Reproduction (2 papers)Journal of Clinical Pathology (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomItalyBelgium
In The Last Decade
Mark Lansdown
43 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 346
- Nephrology 148
- Oncology 541
- Genetics 456
- Pathology and Forensic Medicine 143
Countries citing papers authored by Mark Lansdown
This map shows the geographic impact of Mark Lansdown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lansdown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lansdown more than expected).
Fields of papers citing papers by Mark Lansdown
This network shows the impact of papers produced by Mark Lansdown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lansdown. The network helps show where Mark Lansdown may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lansdown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. | 2000 | 292 |
| 2 | 2003 | 251 | |
| 3 | 2003 | 175 | |
| 4 | 2010 | 142 | |
| 5 | 1990 | 127 | |
| 6 | 2004 | 106 | |
| 7 | 2007 | 104 | |
| 8 | 2001 | 75 | |
| 9 | Culture, attitude and knowledge about breast cancer and preventive measures: a qualitative study of South Asian breast cancer patients in the UK. | 2011 | 60 |
| 10 | 2004 | 57 | |
| 11 | 2005 | 54 | |
| 12 | 2016 | 54 | |
| 13 | 1994 | 49 | |
| 14 | 2005 | 37 | |
| 15 | 2004 | 34 | |
| 16 | 2004 | 30 | |
| 17 | 2009 | 26 | |
| 18 | 1998 | 22 | |
| 19 | 2003 | 22 | |
| 20 | 2021 | 20 |
About Mark Lansdown
Mark Lansdown is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 46 papers that have together received 1.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Thyroid and Parathyroid Surgery (4 papers), Breast Lesions and Carcinomas (4 papers), Parathyroid Disorders and Treatments (4 papers), Breast Cancer Treatment Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Male Breast Health Studies (2 papers). The work is most often cited by research in Cancer Research (346 citations), Nephrology (148 citations), Oncology (541 citations), Genetics (456 citations) and Pathology and Forensic Medicine (143 citations). Mark Lansdown has collaborated with scholars based in United Kingdom, Italy and Belgium. Frequent co-authors include Valerie Speirs, Andrew M. Hanby, P J Carder, Andrew Scarsbrook, Chirag N. Patel, G. Skliris, Sally Lane, Kieran Horgan, Timothy Perren and Ken MacLennan. Their work appears in journals such as British journal of surgery, European Journal of Surgical Oncology, Human Reproduction, Journal of Clinical Pathology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.